Bullous pemphigoid-like rash revealing hypereosinophilic syndrome

Clicks: 204
ID: 271339
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #17 of 19 articles by views in bmj case reports

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Hypereosinophilic syndrome (HES) is a rare haematologic disorder characterised by unexplained, persistent eosinophilia with organ involvement. We report the case of a 74-year-old patient who presented with a pemphigoid-like bullous rash as the only manifestation of an HES. This report highlights the …
Reference Key
m2021bmjbullous Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Khallaayoune M;Sialiti S;Meziane M;Senouci K;;
Journal bmj case reports
Year 2021
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/34103306
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine case reports aged pmid:34103306 pmc8189923 doi:10.1136/bcr-2021-242695 mehdi khallaayoune sanae sialiti karima senouci autoimmune diseases* blister exanthema* / etiology hypereosinophilic syndrome* / complications hypereosinophilic syndrome* / diagnosis hypereosinophilic syndrome* / drug therapy pemphigoid bullous* / diagnosis bullous* / drug therapy bullous* / etiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.